Intarcia

Intarcia is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic diseases.

Business Model:

Revenue: $47.8M

Employees: 201-500

Detailed Intarcia Information

Geographic Data

Intarcia headquarters map

Address: One Marina Park Drive

City: Boston

State: MA

Zip: 02210

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$0

Raised Total:

$2B

Metrics

3,441,799Website Global Rank

4,178Website Monthly Traffic

Twitter Followers

Description

Intarcia is a pharmaceutical company that develops and commercializes novel therapeutics for the treatment of chronic diseases.

Contact Phone:
+16179362500

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
8/1998 Series A $2M
6/2003 Series D 4 $43M Venrock
New Enterprise Associates
InterWest Partners
Alta Partners
Venrock
New Enterprise Associates
InterWest Partners
Alta Partners
5/2016 Debt Financing 2 $75M Silicon Valley Bank
MidCap Financial
4/2014 Venture Round $0 RA Capital Management
Alger
Quadrille Capital
New Leaf Venture Partners
Foresite Capital
Farallon Capital Management
RA Capital Management
Alger
Quadrille Capital
New Leaf Venture Partners
Foresite Capital
Farallon Capital Management
9/2016 Series E $0 The Pritzker Organization
Foresite Capital
The Baupost Group
RA Capital Management
Baillie Gifford
Kayon Partners
Baillie Gifford
NXT Ventures
Fidelity
The Pritzker Organization
Foresite Capital
The Baupost Group
RA Capital Management
Baillie Gifford
Kayon Partners
Baillie Gifford
NXT Ventures
Fidelity
5/2010 Venture Round 1 $14.5M Greenspring Associates
Greenspring Associates
1/2010 Venture Round $9M
8/2000 Venture Round 1 - Bay City Capital
Bay City Capital
2/2019 Debt Financing $73.1M
9/2017 Series E $200M
11/2012 Debt Financing 3 $50M Venrock
New Leaf Venture Partners
New Enterprise Associates
Venrock
New Leaf Venture Partners
New Enterprise Associates
11/2012 Venture Round 7 $160M Venrock
The Baupost Group
New Leaf Venture Partners
New Enterprise Associates
Marker
GGV Capital
Farallon Capital Management
5/2017 Secondary Market 1 - SharesPost Investment Management
SharesPost Investment Management
3/2007 Venture Round 7 $50M Venrock
Quadrille Capital
Omega Funds
New Leaf Venture Partners
New Enterprise Associates
GGV Capital
Alta Partners
Venrock
Quadrille Capital
Omega Funds
New Leaf Venture Partners
New Enterprise Associates
GGV Capital
Alta Partners
8/2012 Debt Financing $45.8M
4/1999 Series B 2 $12.1M InterWest Partners
Alta Partners
InterWest Partners
Alta Partners
8/2019 Venture Round 1 - GGV Capital
GGV Capital
4/2005 Debt Financing 2 $10M Silicon Valley Bank
Horizon Technology Finance
Silicon Valley Bank
Horizon Technology Finance
9/2000 Series C 2 $38M InterWest Partners
Alta Partners
InterWest Partners
Alta Partners
12/2004 Series E 5 $50M Venrock
New Enterprise Associates
InterWest Partners
GGV Capital
Alta Partners
Venrock
New Enterprise Associates
InterWest Partners
GGV Capital
Alta Partners
9/2016 Series E $524.6M Baillie Gifford
Luxin Venture Capital Group Co., Ltd.
The Baupost Group, L.L.C.
Fidelity
Foresite Capital
RA Capital Management
12/2016 Series E 2 $206M GWC Innovator Fund
Bill &a; Melinda Gates Foundation
Bill &a; Melinda Gates Foundation
GWC Innovator Fund
Bill &a; Melinda Gates Foundation
Bill &a; Melinda Gates Foundation
2/2019 Debt $198.5M
12/2016 Equity $3.6k
4/2015 Equity $300M
4/2015 Funding Round $225M
9/2010 Debt Financing 3 $5M Venrock
New Leaf Venture Partners
New Enterprise Associates
Venrock
New Leaf Venture Partners
New Enterprise Associates
8/2019 Venture Round 1 - GGV Capital
GGV Capital
5/2017 Secondary Market 1 - SharesPost Investment Management
SharesPost Investment Management
9/2016 Series E 8 $215M The Pritzker Organization
Foresite Capital
The Baupost Group
RA Capital Management
Baillie Gifford
Kayon Partners
Baillie Gifford
The Pritzker Organization
Foresite Capital
The Baupost Group
RA Capital Management
Baillie Gifford
Kayon Partners
Baillie Gifford
4/2014 Venture Round 6 $200M RA Capital Management
RA Capital Management
Announced Date Name Price
9/2015 Phoundry Pharmaceuticals

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research